tirzepatide weight loss trial results In adults with obesity but not diabetes, leads to significantly greater than semaglutide over 72 weeks, and nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL GLP-1 Users Who Track May

b) Liver Health They reduce fat accumulation in the liver , beneficial for those with non-alcoholic fatty liver disease (NAFLD)

What about green tea

Whilst the neurobiological effects of GLP-1 medications on reward pathways and food-related impulsivity are theoretically relevant, more robust, randomised controlled trials with longer follow-up periods are needed before these medications can be recommended as a standard treatment for binge eating disorder in clinical practice

Clinical evidence shows significant improvements in Type 2 diabetes, sleep apnea, and heart health, along with renewed energy, mobility, and emotional balanceproving that surgery changes how the body functions, not just how it looks